Debt-to-equity in % of Ikena Oncology, Inc. from Q3 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ikena Oncology, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2025.
  • Ikena Oncology, Inc. Debt-to-equity for the quarter ending September 30, 2025 was -16.6 %, a 34.7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

Ikena Oncology, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -16.6 -4.26 -34.7% Sep 30, 2025
Q2 2025 -8.3 +24.1 +74.4% Jun 30, 2025
Q1 2025 -9.44 -180 -106% Mar 31, 2025
Q4 2024 -10.8 -36.6 -142% Dec 31, 2024
Q3 2024 -12.3 -26.7 -185% Sep 30, 2024
Q2 2024 -32.4 -47.4 -317% Jun 30, 2024
Q1 2024 171 +153 +845% Mar 31, 2024
Q4 2023 25.8 +6.73 +35.2% Dec 31, 2023
Q3 2023 14.5 -5.07 -26% Sep 30, 2023
Q2 2023 15 -6.88 -31.5% Jun 30, 2023
Q1 2023 18.1 -5.8 -24.3% Mar 31, 2023
Q4 2022 19.1 -7.45 -28.1% Dec 31, 2022
Q3 2022 19.5 -26.4 -57.4% Sep 30, 2022
Q2 2022 21.8 Jun 30, 2022
Q1 2022 23.9 Mar 31, 2022
Q4 2021 26.6 Dec 31, 2021
Q3 2021 45.9 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.